MET-Test is a leader in providing patient-specific, data-driven technology using state-of-the-art analytical tools, trained specialists, and powerful proprietary pattern recognition software that enable healthcare organizations to optimize medication regimens and improve patient outcomes. This results in reduced hospitalizations, lower healthcare costs, and improved risk management. 

We have tested over 200,000 patients and accumulated real world data. We currently provide services to over 56 clinics in 10 states as well as participating in several clinical trial. We are a privately held corporation headquartered in Atlanta, Georgia.

1  American Heart Association, 2015 Heart Disease and Stroke Statistics Update.

2 Centers for Disease Control and Prevention, Heart Disease Facts.